1. Volume 71, Issue 1, Pages 55-65 (January 2017)
Impact of Prostate-specific Antigen (PSA) Screening Trials and Revised PSA Screening Guidelines on Rates of Prostate Biopsy and Postbiopsy Complications 
Boris Gershman, Holly K. Van Houten, Jeph Herrin, Daniel M. Moreira, Simon P. Kim, Nilay D. Shah, R. Jeffrey Karnes 
European Urology 
Volume 71, Issue 1, Pages (January 2017)
DOI: /j.eururo
Copyright © 2016 European Association of Urology Terms and Conditions

2. Fig. 1
Interrupted time series analysis of monthly rates of prostate biopsy and 30-d complications (January 2005 to September 2014) among men aged ≥40 yr (n= ).
AUA=American Urological Association; ERSPC=European Randomized Study of Screening for Prostate Cancer; PLCO=Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial; USPSTF=US Preventive Services Task Force.
European Urology  , 55-65DOI: ( /j.eururo )
Copyright © 2016 European Association of Urology Terms and Conditions

3. Fig. 2
Interrupted time series analysis of monthly rates of 30-d postbiopsy complications (January 2005 to September 2014) among men aged ≥40 yr undergoing biopsy (n=104584).
AUA=American Urological Association; ERSPC=European Randomized Study of Screening for Prostate Cancer; PLCO=Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial; USPSTF=US Preventive Services Task Force.
European Urology  , 55-65DOI: ( /j.eururo )
Copyright © 2016 European Association of Urology Terms and Conditions